Clinical Trials Directory

Trials / Unknown

UnknownNCT04051931

The Copmparison of Accuracy of PtcCO2 and in PetCO2 in COPD Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
Sex
All
Age
20 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The pathophysiological characteristics of COPD is irreversible airflow restriction which may influence the gas exchange and cause the abnormal PaO2 and PaCO2. Assessment of the partial arterial pressure of carbon dioxide (PaCO2 ) is the 'gold standard' for the evaluation of the adequacy of alveolar ventilation.Method used mostly nowadays : arterial puncture which is accurate but is invasive 、painful、 non-dynamic and there is risk of infection and tissue、nerve damage. Noninvasive measurement methods (Most commonly used): end-tidal CO2( ETCO2)、 transcutaneous CO2(TcCO2). They all can monitor the PaCO2 dynamically、 noninvasively, but is existence of controversy of the accuracy. So the investigators want to compare the accuracy of these two noninvasive methods for assessment of PaCO2.

Conditions

Timeline

Start date
2019-08-10
Primary completion
2020-06-01
Completion
2020-06-01
First posted
2019-08-09
Last updated
2019-10-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04051931. Inclusion in this directory is not an endorsement.

The Copmparison of Accuracy of PtcCO2 and in PetCO2 in COPD Patients (NCT04051931) · Clinical Trials Directory